Showing results (121-130 of 198) with videos related to
Sort By:
Pageof 20
Biorxiv : the Preprint Server for Biology|September 4, 2024
Polyploid cancer cells reveal signatures of chemotherapy resistanceMichael J Schmidt, Amin Naghdloo, Rishvanth K Prabakar, et al.Clinical Genitourinary Cancer|February 14, 2009
Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical researchMichael J Morris, Ethan M Basch, George Wilding, et al.Oncogene|November 23, 2024
Polyploid cancer cells reveal signatures of chemotherapy resistanceMichael J Schmidt, Amin Naghdloo, Rishvanth K Prabakar, et al.Cancer Chemotherapy and Pharmacology|July 22, 2017
Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapyMehmet Asim Bilen, Kenneth R Hess, Sumit K Subudhi, et al.Cancer Research|November 5, 2015
Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate CancerYu-Chen Lee, Song-Chang Lin, Guoyu Yu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2025
Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate CancersJohn K Lin, Jiangong Niu, Sharon H Giordano, et al.Journal of Personalized Medicine|December 23, 2023
Changes in the Liver Transplant Waiting List after Expanding to the 'Up-to-Seven' Criteria for Hepatocellular CarcinomaJavier Manuel Zamora-Olaya, Ana Aparicio-Serrano, Víctor Amado Torres, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2024
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III TrialKarim Fizazi, Gwénaël Le Teuff, Aude Fléchon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2020
Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate CancerPaymaneh D Malihi, Ryon P Graf, Angel Rodriguez, et al.Neoplasia (New York, N.Y.)|January 26, 2016
Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate CancerYuanyuan Qiao, Felix Y Feng, Yugang Wang, et al.Pageof 20